Detection of a previously unrecognized type 2 diabetes with a risk questionnaire: Effectiveness of population-based screening;Nachweis eines bisher unerkannten diabetes mellitus typ 2 mittels risikofragebogen: Effizienz beim allgemeinen populations-screening

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 40, 2006, Pages 2208-2212

  Scherbaum, Werner A ^a,b   Dicken, H D ^a   Verheyen, F ^c   Baehring, T ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c Techniker Krankenkasse   (Germany)

Author keywords

Diabetes mellitus; Risk questionnaire; Screening programme

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POPULATION BASED CASE CONTROL STUDY; QUESTIONNAIRE; SCREENING; GERMANY; GLUCOSE TOLERANCE TEST; HEALTH SURVEY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; RISK FACTOR; STANDARD;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS;

EID: 33750721351     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951353     Document Type: Article

References (25)

1. Adriaanse MC, Snoek FJ, Dekker JM et al. Perceived risk for type 2 diabetes in participants in a stepwise population-screening programme. Diabet Med 2003; 20: 210-215
2. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27: 11-14
3. Baan CA Ruige JB, Stolk RP et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 1999; 22: 213-219
4. Baehring TU, Schulze H, Bornstein SR, Scherbaum WA. Using the World Wide Web - a new approach to risk identification of diabetes mellitus. Int J Med Inf 1997;46:31-39
5. Borch-Johnson K, Lauritzen T, Glümer C, Sandbæk A. Screening for type 1 diabetes - should it be now? Diabet Med 2003; 20: 175-181
6. Christensen JO, Sandbæk A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004; 47: 1566-1573
7. Connelly J, Cooper J, Mann A, Meade TWI. The psychological impact of screening for risk of coronary heart disease in primary care settings. J Cardiovascular Risk 1998; 5: 185-191
8. Reanalysis of European epidemiological data: the DECODE study group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? BMJ 1998; 317: 371-375
9. Franciosi M, De Berardis G, Rossi MC et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO study. Diabetes Care 2005; 28: 1187-1194
10. Glümer C, Carstensen B, Sandbæk A et al. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004; 27: 727-733
11. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171
12. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819
13. Hauner H, Köster I, von Ferber L. Prävalenz des Diabetes mellitus in Deutschland 1998-2001. Sekundärdatenanalyse einer Versichertenstichprobe der AOK Hessen/KV Hessen. Dtsch Med Wochenschr 2003; 128: 2632-2637
14. Herman WH, Engelgau MM, Zhang Y, Brown MB. Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the US population. Diabetes Care 2000;23:1207-1208
15. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18: 382-387
16. Kerner W, Brückel J, Böhm BO. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Aktualisierte Version auf den Webseiten der DDG "www.deutsche-diabetes-gesellschaft.de"/Evidenzbasierte Leitlinien/Definition, Scherbaum WA, Kiess U (Hrsg), Oktober 2004
17. Lehnert H, Wittchen H-U, Pittrow D et al. Prävalenz und Pharmakotherapie des Diabetes mellitus in der primärärztlichen Versorgung. Dtsch Med Wochenschr 2005; 130: 323-328
18. Lindström J, Tuomilehto J. The diabetes risk score: A practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731
19. O'Connor PJ, Rush WA, Cherney LM, Pronk NP. Screening for diabetes mellitus in high-risk patients: cost, yield and acceptability. Eff Clin Pract 2001;4:271-277
20. Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189
21. Ruige JB, Neeling JN de, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-496
22. Spijkerman AM, Adriaanse MC, Dekker JM et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002; 25: 1784-1789
23. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002; 136: 575-581
24. Taubert G, Winkelmann BR, Schleiffer T et al. Prevalence, predictors and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 2003; 145: 285-291
25. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-771